リーズナブル 免疫生物学

出版社: 中外医学社
著者:
発行日: 2019-03-20
分野: 基礎医学  >  免疫/血清
ISBN: 9784498106086
電子書籍版: 2019-03-20 (1版1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:8~14営業日

5,720 円(税込)

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

5,720 円(税込)

商品紹介

“現存する生物は、下等動物であれ、高等動物であれ、それぞれ解剖学的あるいは生理学的には完成品に近い”という著者の考えに基づき、単著でまとめられた免疫学の新たなテキストブック。著者がそう解釈する理由(reason)として多数の論文を引用し、免疫学の全容を初学者にもわかるよう平易に解説した。

目次

  • 1 免疫生物学序論
    2 免疫生物系の構成
    3 B細胞免疫
    4 T細胞免疫
    5 主要組織適合性抗原と移植免疫
    6 自然免疫
    7 マクロファージによる同種異系移植片拒絶
    8 獲得免疫
    9 腸管での免疫応答
    10 母体と胎児
    11 サイトカイン
    12 ウイルス感染と免疫
    13 プリオン
    14 過敏症
    15 がん免疫の基礎と臨床
    16 自己免疫疾患
    17 生活習慣病

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

文献

P.207 掲載の参考文献
4. Urade Y., Yoshida R., Kitamura H., and Hayaishi O. (1983) Induction of indoleamine 2,3-dioxygenase in alveolar interstitial cells of mouse lung by bacterial lipopolysaccharide. J. Biol. Chem. 258 : 6621-6627.
5. Takikawa O., Yoshida R., and Hayaishi O. (1983) Monooxygenase activities of dioxygenases. J. Biol. Chem. 258 : 6808-6815.
6. Watanabe K., Yoshida R., Shimizu T., and Hayaishi O. (1985) Enzymatic formation of prostaglandin F2α from prostaglandin H2 and D2. J. Biol. Chem. 260 : 7035-7041.
13. Dalloul A. H., Chmouzis E., Ngo K., and Fung-Leung W. P. (1996) Adoptively transferred CD4+ lymphocytes from CD8-/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J. Immunol. 156 : 4114-4119.
18. Yoshida R., Park S. W., Yasui H., and Takikawa O. (1988) Tryptophan degradation in transplanted tumor cells undergoing rejection. J. Immunol. 141 : 2819-2823.
21. Sanchez-Bueno A., Verkhusha V., Tanaka Y., Takikawa O., and Yoshida R. (1996) Interferon-γ-dependent expression of inducible nitric oxide synthase, interleukin-12, and interferon-γ-inducing factor in macrophages elicited by allografted tumor cells. Biochem. Biophys. Res. Commun. 224 : 555-563.
24. Yoshida R., Sanchez-Bueno A., Yamamoto N., and Einaga-Naito K. (1997) Ca2+ -dependent, Fas- and perforinindependent apoptotic death of allografted tumor cells by a type of activated macrophage. J. Immunol. 159 : 15-21.
27. Yoneda Y., and Yoshida R. (1998) The role of T cells in allografted tumor rejection : IFN-γ released from T cells is essential for induction of effector macrophages in the rejection site. J. Immunol. 160 : 6012-6017.
28. Hirota R., Tajima S., Yoneda Y., Tamayama T., Watanabe M., Ueda K., Kubota T., and Yoshida R. (2002) Alopecia of IFN-γ knockout mouse as a model for disturbance of the hair cycle : A unique arrest of the hair cycle at the anagen phase accompanied by mitosis. J. Interferon Cytokine Res. 22 : 935-945.
29. Yoshida R., Yoneda Y., Kuriyama M., and Kubota T. (1999) IFN-γ- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophage against syngeneic tumor cells and cell lines : An application of allografting to cancer treatment. J. Immunol. 163 : 148-154.
54. Yoshida R., Murray H. W., and Nathan C. F. (1988) Agonist and antagonist effects of interferon-α and -β on activation of human macrophages : Two classes of interferon-γ receptors and blockade of the high-affinity sites by interferon-α or -β. J. Exp. Med. 167 : 1171-1185.
64. Evans R. L., Lazarus H., Penta A. C., and Schlossman S. F. (1978) Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. J. Immunol. 120 : 1423-1428.
70. Fadok V. A., Laszlo D. J., Noble P. W., Weinstein L., Riches D. W., and Henson P. M. (1993) Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. J. Immunol. 151 : 4274-4285.
79. Cohen S., and Levi-Montalcini R. (1957) Purification and properties of a nerve growth-promoting factor isolated from mouse sarcoma 180. Cancer Res. 17 : 15-20.
82. Nagano Y., Kojima Y., and Sawai Y. (1954). Immunity and interference in vaccinia; inhibition of skin infection by inactivated virus. C. R. Seances. Soc. Biol. Fil. 148 : 750-752.
91. Hirota R., Tajima S., Yoneda Y., Okada M., Tashiro J., Ueda K., Kubota T., and Yoshida R. (2003) Induction of hair regrowth in the alopecia site of IFN-γ knockout mice by allografting and IFN-γ injection into the transplantation site. J. Interferon Cytokine Res. 23 : 433-439.
92. Okada M., Tashiro-Yamaji J., Takahashi T., Nomi H., Yamamoto Y., Yamaguchi S., Ueda K., Kubota T., and Yoshida R. (2005) Regulation of hair regrowth in alopecic site of IFN-γ-/- mice by macrophages infiltrating into allograft in IFN-γ+/+ mice. J. Interferon Cytokine Res. 25 : 564-574.
93. Yoneda Y., Hirota R., Tashiro J., Okada M., Lee K., Ueda K., Kubota T., and Yoshida R. (2003) Cellular origin of IFN-γ essential for hair cycle in normal skin. J. Interferon Cytokine Res. 23 : 299-305.
94. Fleming T. J., Fleming M. L., and Malek T. R. (1993) Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151 : 2399-2408.
97. Kunisada T., Yoshida H., Yamazaki H., Miyamoto A., Hemmi H., Nishimura E., Shultz L. D., Nishikawa S., and Hayashi S. (1998) Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors. Development 125 : 2915-2923.
114. Horwitz M. S., Krahl T., Fine C., Lee J., and Sarvetnick N. (1999) Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J. Virol. 73 : 1756-1766.
116. Kyuwa S., Tagawa Y., Shibata S., Doi K., Machii K., and Iwakura Y. (1998) Murine coronavirus-induced subacute fatal peritonitis in C57BL/6 mice deficient in gamma interferon. J. Virol. 72 : 9286-9290.
117. Binder G. K., and Griffin D. E. (2001) Interferon-γ-mediated site-specific clearance of alphavirus from CNS neurons. Science 293 : 303-306.
118. Geiger K. D., Nash, T. C., Sawyer S., Krahl T., Patstone G., Reed J. C., Krajewski S., Dalton D., Buchmeier M. J., and Sarvetnick N. (1997) Interferon-γ protects against herpes simplex virus type-1-mediated neuronal death. Virology 238 : 189-197.
120. Yamaguchi S., Tashiro-Yamaji J., Lee K., Takahashi T., Sano K., Endo Y., Nakanishi M., Eguchi A., Okada M., Nomi H., Yamamoto Y., Takenaka H., Kubota T., and Yoshida R. (2005) IFN-γ : A cytokine essential for rejection of CTL-resistant virus-infected cells. J. Interferon Cytokine Res. 25 : 328-337.
126. Sumegi J., Uzvolgyi E., and Klein G. (1990) Expression of the RB gene under the control of MuLV-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblastoma cells in immunodefective mice. Cell Growth Differ. 1 : 247-250.
128. Okada Y., and Hosokawa Y. (1961) Isolation of a new variant of HVJ showing low cell fusion activity. Biken J. 4 : 217-220.
131. Plummer P. J. (1946) Scrapie-A Disease of Sheep : A Review of the literature. Can. J. Comp. Med. Vet. Sci. 10 : 49-54.
137. Coombs R. R. A., and Gell P. G. H. (1968) Clinical Aspects of Immunology, 1st edition, p. 575, Blackwell Scientific Publications, Oxford.
140. Coffman R., Ohara J., Bond M., Carty J., Zlotnik A., and Paul W. E. (1986) B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immunol. 136 : 4538-4541.
141. Paul W. E. (1991) Interleukin-4 : a prototypic immunoregulatory lymphokine. Blood 77 : 1859-1870.
142. Ricci M., Matsuci A., and Rocci O. (1997) IL-4 as a key factor influencing the development of allergen-specific Th2-like cells in atopic individuals. J. Invest. Allergol. Clin. Immunol. 7 : 144-150.
145. Yuan D., Weiss E. A., Layton J. E., Krammer P. H., and Vitetta E. S. (1985) Activation of the γ1 gene by lipopolysaccharide and T-cell-derived lymphokines containing a B cell differentiation factor for IgG1 [BCDFγ]. J. Immunol. 135 : 1465-1469.
150. Krusmeier M., and Snow E. C. (1988) Induction of lymphokine responsiveness of hapten-specific B lymphocytes promoted through an antigen-mediated T helper lymphocyte interaction. J. Immunol. 190 : 367-375.
151. Whalen B. J, Tony H. P., and Parker D. C. (1988) Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines. J. Immunol. 141 : 2230-2239.
157. Nowell P., and Hungerford D. (1960) A minute chromosome in chronic granulocytic leukemia. Science 132 : 1497.
173. Farr L. E., Sweet W. H., Robertson J. S., Foster C. G., Locksley H. B., Sutherland D. L., Mendelsohn M. L., and Stickley E. E. (1954) Neutron capture therapy with boron in the treatment of glioblastoma multiforme. Am. J. Roentgenol. Radium. Ther. Nucl. Med. 71 : 279-293.
182. Allione A., Consalvo M., Nanni P., Lollini P. L., Cavallo F., Giovarelli M., Forni M., Gulino A., Colombo M. P., Dellabona P., Hock H., Blankenstein T., Rosenthal F. M., Gansbacher B., Bosco M. C., Musso T., Gusella L., and Forni G. (1994) Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL) -2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants. Cancer Res. 54 : 6022-6026.
187. Midorikama Y., Yamashita T., and Sendo F. (1990) Modulation of the immune response to transplanted tumors in rats by selective depletion of neutrophils in vivo using a monoclonal antibody : abrogation of specific transplantation resistance to chemical carcinogen-induced syngeneic tumors by selective depletion of neutrophils in vivo. Cancer Res. 50 : 6243-6247.
190. Hu H. M., Urba W. J., and Fox B. A. (1998) Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from a type 2 to a type 1 cytokine profile. J. Immunol. 161 : 3033-3041.
192. Tanaka H., Yoshizawa H., Yamaguchi Y., Ito K., Kagamu H., Suzuki E., Gejyo F., Hamada H., and Arakawa M. (1999) Successful adoptive immunotherapy of murine poorly immunogenic tumors with specific effector cells generated from gene-modified tumor-primed lymph node cells. J. Immunol. 162 : 3574-3582.
193. Kjaergaard J., and Shu S. (1999) Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression. J. Immunol. 163 : 751-759.
194. Mukai S., Kjaergaard J., Shu S., and Plautz G. E. (1999) Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res. 59 : 5245-5249.
197. Shrieve D. C., Deen D. F., and Harris J. W. (1983) Effects of extreme hypoxia on the growth and viability of EMT6/SF mouse tumor cells in vitro. Cancer Res. 43 : 3521-3527.
199. Leek R. D., Lewis C. E., Whitehouse R., Greenall M., Clarke J., and Harris A. L. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56 : 4625-4629.
200. Negus R. P., Stamp G. W., Hadley J., and Balkwill F. R. (1997) Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol. 150 : 1723-1734.
201. Burton J. L., Wells J. M., Corke K., Maitland N., Hamdy F. C., and Lewis C. E. (2000) Macrophages accumulate in avascular, hypoxic areas of prostate tumors : implications for the targeted therapeutic gene delivery to such sites. J. Pathol. 192 : 8A.
203. Ohno S., Ohno Y., Suzuki N., Kamei T., Koike K., Inagawa H., Kohchi C., Soma G.-I., and Inoue M. (2004) Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res. 24 : 3335-3342.
205. Klemperer P. (1947) Diseases of the collagen system. Bull. N. Y. Acad. Med. 23 : 581-588.
208. Gregerson D. S., Obritsch W. F., Fling S. P., and Cameron J. D. (1986) S-antigen-specific rat T cell lines recognize peptide fragments of S-antigen and mediate experimental autoimmune uveoretinitis and pinealitis. J. Immunol. 136 : 2875-2882.
209. Mochizuki M., Kuwabara T., McAllister C., Nussenblatt R. B., and Ger y I. (1985) Adoptive transfer of experimental autoimmune uveoretinitis in rats : immunopathogenic mechanisms and histologic features. Invest. Opthalmol. Vis. Sci. 26 : 1-9.
210. Caspi R. R., Roberge F. G., McAllister C., el-Saied M., Kuwabara T., and Gery I. (1986) T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J. Immunol. 136 : 928-933.
213. Meehan T. F., and DeLuca H. F. (2002) CD8+ T cells are not necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice. Proc. Natl. Acad. Sci. USA. 99 : 5557-5560.
215. Duncan T., Fariss R. N., and Wiggert B. (2006) Confocal immunolocalization of bovine serum albumin, serum retinol-binding protein, and interphotoreceptor retinoid-binding protein in bovine retina. Mol. Vis. 12 : 1632-1639.
216. Borst D. E., Redmond T. M., Elser J. E., Gonda M. A., Wiggert B., Chader G. J., and Nickerson J. M. (1989) Interphotoreceptor retinoid-binding protein : gene characterization, protein repeat structure, and its evolution. J. Biol. Chem. 264 : 1115-1123.
219. Caspi R. R., Roberge F. G., Chan C. C., Wiggert B., Chader G. J., Rozenszain L. A., Lando Z., and Nussenblatt R. B. (1988) A new method of autoimmune disease : experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140 : 1490-1495.
221. Jiang H.-R., Lumsden L., and Forrester J. V. (1999) Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest. Ophthalmol. Vis. Sci. 40 : 3177-3185.
225. Butler T. L., and McMenamin G. (1996) Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis. Invest. Opthalmol. Vis. Sci. 37 : 2195-2210.
228. Robertson M., Liversidge J., Forrester J. V., and Dick A. D. (2003) Neutralizing tumor necrosis factor-α activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis. Invest. Opthalmol. Vis. Sci. 44 : 3034-3041.
231. Gordon I. (1947) Mechanism of lipophage deposition in atherosclerosis. Arch Patho (l Chic). 44 : 247-260.

最近チェックした商品履歴

Loading...